Streamlining Univera Healthcare Eliquis Prior Authorization Workflows
Navigating the complexities of Univera Healthcare Eliquis prior authorization is a critical challenge for revenue cycle and prior authorization teams. Klivira automates the submission process, directly integrating with your EMR.
For clinics and health systems, managing prior authorizations for high-volume medications like Eliquis (apixaban) under specific payer plans such as Univera Healthcare demands precise and efficient workflows. Delays in securing approval for this direct oral anticoagulant (DOAC) can impact patient care continuity and revenue cycles. Understanding Univera's specific requirements is key to minimizing denials and accelerating time-to-therapy.
Univera Healthcare Formulary Considerations for Eliquis (Apixaban)
Eliquis, a critical DOAC for indications such as atrial fibrillation and VTE, often faces specific formulary placement within Univera Healthcare's benefit designs. While specific tiers can vary by individual plan, DOACs are frequently subject to prior authorization and may be positioned on higher formulary tiers, impacting patient out-of-pocket costs and necessitating robust PA processes.
Common Prior Authorization Hurdles for Eliquis with Univera Healthcare
Univera Healthcare's clinical criteria for Eliquis (apixaban) commonly include step-therapy protocols, often requiring documented failure or contraindication to less expensive alternatives like warfarin, or even other DOACs. Additionally, quantity limits may apply, necessitating justification for higher dosages or extended durations. Accurate and timely submission of clinical documentation is paramount to overcoming these hurdles.
PBM and Specialty Pharmacy Routing for Univera Healthcare Eliquis Submissions
Univera Healthcare, like many regional payers, partners with a Pharmacy Benefit Manager (PBM) to administer its prescription drug benefits. This PBM dictates the electronic prior authorization (ePA) routing for drugs like Eliquis. Depending on the specific Univera plan and benefit design, Eliquis may also be routed through a designated specialty pharmacy network for fulfillment, adding another layer of coordination to the PA process.
Key Documentation for Univera Healthcare Eliquis PA Submissions
- Patient's diagnosis (e.g., non-valvular atrial fibrillation, DVT/PE treatment)
- Relevant lab results (e.g., renal function, liver function, INR if applicable)
- History of prior anticoagulant therapy, including dates and outcomes
- Clinical rationale for Eliquis over alternative anticoagulants (e.g., contraindication to warfarin, intolerance to other DOACs)
- Prescribing physician's notes supporting medical necessity
Automating Univera Healthcare Eliquis Prior Authorization with Klivira
Klivira provides a robust solution for automating Univera Healthcare Eliquis prior authorization submissions. Our platform integrates directly with your EMR, leveraging SMART on FHIR standards to extract necessary clinical data and populate X12 278 or NCPDP SCRIPT ePA forms. This reduces manual data entry, minimizes errors, and accelerates the submission process, allowing your team to focus on patient care rather than administrative tasks.
Ensuring Compliance and Data Integrity in PA Workflows
When managing prior authorizations for medications like Eliquis, adherence to HIPAA regulations and the secure handling of ePHI are non-negotiable. Klivira's platform is designed with stringent security protocols to ensure data integrity and compliance throughout the entire PA lifecycle. Organizations should also consider discussing their automated PA workflows with their compliance team to ensure alignment with internal policies and payer requirements.
Frequently asked questions
What is the typical formulary status of Eliquis (apixaban) with Univera Healthcare plans?
While specific formulary tiers can vary by individual Univera Healthcare plan design, Eliquis (apixaban) is commonly placed on a higher formulary tier and often requires prior authorization. This is standard for many direct oral anticoagulants (DOACs) across various payer plans.
Does Univera Healthcare require step therapy for Eliquis?
Yes, Univera Healthcare frequently implements step-therapy requirements for Eliquis. This typically means that patients may need to demonstrate a trial and failure, or a contraindication, to alternative anticoagulants like warfarin or other DOACs before Eliquis is approved. Comprehensive clinical documentation is essential.
How can Klivira help with Univera Healthcare Eliquis prior authorizations?
Klivira automates the prior authorization process by integrating with your EMR to extract relevant clinical data for Eliquis. Our platform then populates and submits ePA requests to Univera Healthcare's PBM, reducing manual effort, improving accuracy, and accelerating approval times for apixaban.
What documentation is most critical for a successful Univera Healthcare Eliquis PA?
Key documentation includes the patient's specific diagnosis (e.g., atrial fibrillation, VTE), a clear clinical rationale for Eliquis over alternatives, and a history of previous anticoagulant therapy. Ensuring all required fields are accurately completed in the ePA submission is also vital.
Can Klivira handle the various submission methods for Univera Healthcare PAs?
Klivira supports various ePA submission methods, including X12 278 and NCPDP SCRIPT, facilitating efficient communication with Univera Healthcare's PBM. Our system is designed to adapt to payer-specific requirements, ensuring your Eliquis PA requests are routed correctly.
Related coverage
Ready to automate prior auth for this plan?
See how Klivira automates prior authorizations for your team.
Request a demo